The Complete Ambien (Zolpidem) Buying Guide

What Is Ambien?

Ambien is the brand name for zolpidem tartrate, a medication belonging to the non-benzodiazepine hypnotic class (specifically an imidazopyridine). It is used for the short-term treatment of insomnia, particularly difficulty falling asleep (sleep-onset insomnia).

Although zolpidem is not technically a benzodiazepine, it acts on the same receptor system — the GABA-A receptor — and carries similar risks for dependence, tolerance, and withdrawal. It was first approved by the FDA in 1992.

Ambien is available in two formulations: immediate-release (IR) tablets for sleep-onset insomnia and controlled-release (CR) tablets for patients who have difficulty both falling asleep and staying asleep (sleep-maintenance insomnia).

How Ambien Works

Zolpidem enhances the effect of gamma-aminobutyric acid (GABA), the primary inhibitory neurotransmitter in the brain. It acts as a positive allosteric modulator of the GABA-A receptor.

Unlike benzodiazepines, which bind to multiple subtypes of the GABA-A receptor, zolpidem has preferential selectivity for the a1 subunit of the GABA-A receptor. This subunit is primarily concentrated in brain regions that regulate sleep and sedation, which is why zolpidem produces strong sedative effects with less anxiolytic and muscle relaxant activity compared to traditional benzodiazepines.

By binding to the a1-containing GABA-A receptors, zolpidem increases the frequency of chloride channel opening in response to GABA, which hyperpolarizes neurons and reduces their excitability. The result is rapid onset of drowsiness and facilitation of sleep initiation.

Zolpidem's selectivity for the a1 subunit explains its potent sedative effect but also why it does not provide the anti-anxiety or muscle relaxant effects typical of non-selective benzodiazepines like diazepam or alprazolam.

FDA Schedule & Classification

IR vs. CR Comparison

Dosage & Administration

Ambien IR (Immediate-Release)

Ambien CR (Controlled-Release)

Important Dosing Instructions

• Take immediately before bedtime — only take when you have a full night (7—8 hours) available for sleep
• Take on an empty stomach — high-fat meals delay absorption and may reduce effectiveness
• Do not take with or after meals
• Do not exceed the recommended dose — the FDA lowered recommended doses in 2013 due to next-morning impairment concerns
• Do not re-dose during the same night if you wake up before your full sleep period is complete
• Do not use for more than 4—5 weeks without medical reassessment

Side Effects

Common Side Effects

These are the most frequently reported side effects of zolpidem:

• Drowsiness next morning — especially at higher doses or when fewer than 8 hours of sleep are available
• Dizziness
• Headache
• Diarrhea
• Nausea and vomiting
• Dry mouth
• Muscle pain (myalgia)
• Fatigue
• Drug withdrawal syndrome — if abruptly discontinued after prolonged use
• Anterograde amnesia — difficulty forming new memories after taking the medication

Serious Side Effects

Contact your healthcare provider or seek emergency medical attention if you experience:

• Complex sleep behaviors — sleepwalking, sleep-driving, making phone calls, preparing/eating food, engaging in sexual activity with no memory (see dedicated section below)
• Severe allergic reaction (anaphylaxis) — hives, difficulty breathing, facial/throat swelling
• Respiratory depression — especially when combined with opioids or other CNS depressants
• Severe drowsiness / sedation that interferes with next-morning activities
• Mood changes — depression, suicidal thoughts, agitation, aggression
• Hallucinations
• Decreased alertness — impaired driving or operating machinery ability the next morning

Complex Sleep Behaviors — FDA Boxed Warning

Reported complex sleep behaviors with zolpidem include:

• Sleep-driving — driving a motor vehicle with no memory of the event
• Sleepwalking — leaving the bed and walking around the house
• Preparing and eating food — cooking meals or eating in a sleep state
• Making phone calls — sending texts or making phone calls without memory
• Engaging in sexual activity — with no conscious awareness
• Performing other complex behaviors — any activity performed while not fully awake

What to do if this occurs:

• Stop taking Ambien immediately
• Contact your healthcare provider to report the event
• Do not drive or engage in activities requiring alertness after taking zolpidem
• Ensure family members or caregivers are aware of this risk

In 2019, the FDA required the addition of this boxed warning after reviewing post-marketing adverse event reports. The agency emphasized that these behaviors can occur at the recommended dose, not only at higher-than-recommended doses.

Precautions & Warnings

• Next-morning impairment: Even at recommended doses, zolpidem can cause next-morning drowsiness that impairs driving and other activities requiring alertness. The FDA recommends avoiding these activities the morning after taking zolpidem if you are unsure whether you are fully alert.
• Dependence and withdrawal: Zolpidem carries risk of both psychological and physical dependence. Withdrawal symptoms can include rebound insomnia, anxiety, tremors, and seizures. Taper gradually under medical supervision.
• CNS depression: Zolpidem enhances GABA activity. Concurrent use with opioids, benzodiazepines, alcohol, or other CNS depressants increases the risk of respiratory depression, profound sedation, coma, and death.
• Pregnancy: FDA Pregnancy Category C. Zolpidem should be used during pregnancy only if potential benefit justifies potential risk. Limited data in pregnant women.
• Breastfeeding: Zolpidem is excreted in breast milk. Use in nursing mothers is not recommended.
• Elderly patients: Increased sensitivity to zolpidem. Start at 5 mg (IR) or 6.25 mg (CR). Higher risk of falls, fractures, and cognitive impairment.
• Hepatic impairment: Reduced clearance of zolpidem. Use lower doses and avoid in severe hepatic impairment.
• Respiratory conditions: Use caution in patients with sleep apnea, COPD, or other respiratory conditions — CNS depressants can suppress respiratory drive.
• Depression: Monitor for worsening depression or suicidal ideation. Zolpidem may unmask or worsen depression.
• Concurrent serotonergic medications: Rare cases of serotonin syndrome have been reported with zolpidem.